Remove 2022 Remove Licensing Remove Molecular Biology Remove Regulations
article thumbnail

Europe: Where is the drug discovery innovation?

Drug Discovery World

In 2022, the continent held a 22.4% Study 2022-503113-31-00-IN-002 is a multi-centre clinical trial to investigate the efficacy of Orexa’s lead compound ORE-001 in the prevention of postoperative ileus. Europe is traditionally a life sciences powerhouse, with a strong tradition in pharmaceutical discovery.

Drugs 147
article thumbnail

Where is the promise for plant-based medicines? Part 1: Cannabis  

Drug Discovery World

Medical cannabis is often a first-thought when regarding plant-based medicines, but there remains public scepticism, arguably due to the regulations relating to the substance. Even still, these approved drug products require a licensed healthcare provider’s prescription. What is the regulatory landscape of medical cannabis?

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Gamma delta T cells: a rising star in cancer therapy

Drug Target Review

Dr Rochlin earned a PhD in Molecular Biology and Genetics from Weill Cornell Medical College, conducting research at Sloan Kettering Institute, and a BA in Biology from the University of Pennsylvania. Normality sensing licenses local T cells for innate-like tissue surveillance. Nat Immunol 23:411-422 (2022).

Therapies 105
article thumbnail

Codon Digest: Seeing Colors After Gene Therapy

Codon

.” Wellcome Collection , London I wrapped up my series on “30 Days of Great Biology Papers.” ” This was a series of tweets in which I told brief stories behind seminal papers, mostly in molecular biology and biophysics. You can read all of them here. And it’s true, but only in an incomplete way.

article thumbnail

Codon Digest: Seeing Colors After Gene Therapy

Codon

.” Wellcome Collection , London I wrapped up my series on “30 Days of Great Biology Papers.” ” This was a series of tweets in which I told brief stories behind seminal papers, mostly in molecular biology and biophysics. You can read all of them here. And it’s true, but only in an incomplete way.

article thumbnail

The Codon Guide to Synthetic Biology

Codon

Credit: Bruce Wetzel and Harry Schaefer, NCI, NIH | License Progress in biology is arguably moving faster today than at any point in the course of human history. Engineered biology has profound potential to change how we live, but the field has become broad, bloated, nebulous. Journal of Molecular Biology (1961).

DNA 91
article thumbnail

The Codon Guide to Synthetic Biology

Codon

Credit: Bruce Wetzel and Harry Schaefer, NCI, NIH | License Last edit: 13 September 2023 Progress in biology is arguably moving faster today than at any point in the course of human history. Engineered biology has profound potential to change how we live, but the field has become broad, bloated, nebulous. Synthesis.cc (2022).

DNA 52